Ln(3+)-doped hydroxyapatite nanocrystals: controllable synthesis and cell imaging

Prior research has shown that hydroxyapatite (HAp) nanocrystals are widely used in biomedical applications due to their biocompatibility and structural similarity to bone. However, a gap remains in understanding how rare-earth doping affects their optical and morphological properties. Established methods focus on undoped HAp for drug delivery or bone regeneration. This paper introduces novel strategies to dope HAp with Ln(3+) ions, which could expand their use in bioimaging. No prior work had resolved how doping dosage influences nanocrystal shape and fluorescence. That uncertainty drove the investigation into tunable synthesis methods. Existing studies have not fully explored the impact of two-step doping processes on morphology. This paper's contribution lies in demonstrating how synthetic routes affect both optical and structural properties. The need for hydrophilic HAp:Ln(3+) particles for cell imaging remains unmet in current literature.

The aim of this study is to investigate how rare-earth doping influences the morphology and fluorescence of HAp nanocrystals. Researchers propose that varying doping levels could control nanocrystal shape and optical properties. The specific problem addressed is the lack of tunable synthesis methods for Ln(3+)-doped HAp. The motivation stems from the need for brighter and more controllable luminescent nanomaterials in cell imaging. The study also seeks to develop hydrophilic HAp:Ln(3+) particles suitable for biological applications. Prior methods lacked control over aspect ratios and fluorescence intensity. This work aims to bridge the gap between synthetic control and functional application. The researchers hypothesize that a second hydrothermal process could preserve original morphology while enhancing luminescence.

The study employs two distinct hydrothermal synthetic approaches to prepare HAp:Ln(3+) nanocrystals. The first method uses a one-pot process with varying rare-earth doping dosages. The second method involves doping pre-synthesized HAp nanorods in a secondary hydrothermal step. Both strategies aim to control nanocrystal morphology and fluorescence. The researchers use Eu(3+) and Tb(3+) ions as dopants to achieve red or green luminescence. Morphological changes are analyzed using electron microscopy and optical spectroscopy. The nanocrystals are functionalized with Pluronic F127 to improve hydrophilicity. Cell imaging experiments are conducted to assess the practical application of these nanocrystals.

The one-pot synthesis produces nanocrystals with tunable aspect ratios and weak fluorescence. As doping dosage increases, nanocrystals evolve from nanorods to nanowires. The second hydrothermal process preserves original nanorod morphology while enhancing luminescence. Doping with Tb(3+) results in bright green emission, while Eu(3+) produces red emission. The nanorods have a diameter of 8 nm and length of 150 nm. Functionalization with Pluronic F127 successfully converts hydrophobic particles into hydrophilic ones. These particles are applied to live cell imaging with strong optical signals. The study confirms that both synthetic strategies yield HAp:Ln(3+) nanocrystals suitable for bioimaging.

The authors suggest that the one-pot synthesis allows for tunable nanocrystal morphology but weak fluorescence. The second hydrothermal process preserves morphology while enhancing luminescence. Both strategies are viable for preparing HAp:Ln(3+) nanocrystals with controlled optical properties. The study proposes that Tb(3+) and Eu(3+) doping can produce bright green or red emission. Functionalization with Pluronic F127 is essential for hydrophilic conversion. The nanocrystals are suitable for cell imaging due to their strong optical properties. The authors propose that these findings could expand the use of HAp nanocrystals in biomedical imaging. The study concludes that both synthetic methods contribute to the development of tunable luminescent nanomaterials.